Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short‐term culture of tumor slices

M Peria, J Donnadieu, C Racz, JF Ikoli… - Head & …, 2016 - Wiley Online Library
Background Cetuximab is a targeted therapy with demonstrated efficacy in the management
of head and neck squamous cell carcinoma (HNSCC). However, no laboratory assay is …
被引用次数：16 相关文章

Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short-term culture of tumor slices

M Peria, J Donnadieu, C Racz, JF Ikoli, A Galmiche… - Head & Neck, 2016 - hal.science
Background. Cetuximab is a targeted therapy with demonstrated efficacy in the management
of head and neck squamous cell carcinoma (HNSCC). However, no laboratory assay is …

Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short-term culture of tumor slices

M Peria, J Donnadieu, C Racz, JF Ikoli… - Head & …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Cetuximab is a targeted therapy with demonstrated efficacy in the management
of head and neck squamous cell carcinoma (HNSCC). However, no laboratory assay is …

Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short-term culture of tumor slices.

M Peria, J Donnadieu, C Racz, JF Ikoli, A Galmiche… - Head & …, 2015 - europepmc.org
Background Cetuximab is a targeted therapy with demonstrated efficacy in the management
of head and neck squamous cell carcinoma (HNSCC). However, no laboratory assay is …

Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short‐term culture of tumor slices

M Peria, J Donnadieu, C Racz, JF Ikoli, A Galmiche… - Head & Neck, 2016 - infona.pl
Background Cetuximab is a targeted therapy with demonstrated efficacy in the management
of head and neck squamous cell carcinoma (HNSCC). However, no laboratory assay is …

Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short-term culture of tumor slices.

M Peria, J Donnadieu, C Racz, JF Ikoli… - Head & …, 2016 - search.ebscohost.com
ABSTRACT Background Cetuximab is a targeted therapy with demonstrated efficacy in the
management of head and neck squamous cell carcinoma (HNSCC). However, no laboratory …

Evaluation of individual sensitivity of head and neck squamous cell carcinoma to cetuximab by short-term culture of tumor slices

M Peria, J Donnadieu, C Racz, JF Ikoli… - Head & …, 2016 - u-picardie.hal.science
Background. Cetuximab is a targeted therapy with demonstrated efficacy in the management
of head and neck squamous cell carcinoma (HNSCC). However, no laboratory assay is …